Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Molecules/Midostaurin

Midostaurin

N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide

C35H30N4O4570.60 g/molCID 9829523
Compare

Molecular Identity

Midostaurin

N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide

PubChem CID: 9829523

Midostaurin is an organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine. It has a role as an antineoplastic agent and an EC 2.7.11.13 (protein kinase C) inhibitor. It is a member of benzamides, an organic heterooctacyclic compound, an indolocarbazole and a gamma-lactam. It is functionally related to a staurosporine.

2D Structure

2D structure of Midostaurin

Properties

C35H30N4O4
Molecular Formula
570.60
Molecular Weight
g/mol
570.2267
Exact Mass
Da
4.8
XLogP
Drug-like (Lipinski: < 5)
77.7
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
4
H-Bond Acceptors
1140
Complexity

SMILES

Canonical SMILES

SMILES:

Synonyms(20)

Midostaurin120685-11-2PKC412Cgp 41251PKC 412PKC-412RYDAPTCGP-41251BenzoylstaurosporineN-BenzoylstaurosporinemidostaurinamidostaurineCgp 41 251ID912S5VONNVP-PKC412
Data from PubChem (NCBI)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Molecular Structure

Midostaurin

Loading structure...

2D molecular structure of Midostaurin
Source: PubChem

Drug Network

Trials and conditions connected to Midostaurin

Loading drug network...